title: Recombinant human TSH associated with radioiodine does not have further effects on thyroid volume and function after 2 years.
authors.forename: G J
authors.initials: GJ
authors.lastname: Paz-Filho
authors.forename: C O
authors.initials: CO
authors.lastname: Mesa
authors.forename: G A
authors.initials: GA
authors.lastname: Carvalho
authors.forename: C A
authors.initials: CA
authors.lastname: Goedert
authors.forename: H
authors.initials: H
authors.lastname: Graf
mesh_terms: D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006044:Goiter, Nodular / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology / Q000532:radiotherapy*; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D009929:Organ Size / Q000187:drug effects / Q000528:radiation effects; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use; D013961:Thyroid Gland / Q000187:drug effects / Q000473:pathology* / Q000503:physiopathology* / Q000528:radiation effects; D013972:Thyrotropin / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D007457:Iodine Radioisotopes; D011994:Recombinant Proteins; D013972:Thyrotropin